Frequently Asked Questions
The market is segmented based on , By Types (Acute and Chronic), Diagnosis (Medical history, MRI, CT Scan, Physical and Neurological Examination), Treatment (Ventriculoperitoneal Shunt, Third Ventriculostomy), Causes (Head Trauma, Stroke, Bleeding, Central Nervous System Tumors, Surgery Complications), Symptoms (Irritability, Headache, Nausea, Cognitive Changes, Seizures, Vision Problems, Personality Changes), End-Users (Clinics, Hospitals, Diagnostic centres, Home healthcare, others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Obstructive Hydrocephalus Market size was valued at USD 2733.72 USD Million in 2022.
The Global Obstructive Hydrocephalus Market is projected to grow at a CAGR of 7.3% during the forecast period of 2023 to 2030.
The major players operating in the market include DePuy Synthes, Boston Neuropsychological services, Medtronic, Integra Life Sciences, Spiegelberg GmbH & Co. KG, Sophysa, Terumo Corporation, Natus Medical orporated, Johnson & Johnson Private limited, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, TKB Corporation.
The market report covers data from the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa..
